The molecular genetics of autoimmune liver disease
暂无分享,去创建一个
[1] S. Kaufmann. Heat shock proteins and immune response. , 2011, Current topics in microbiology and immunology.
[2] M. Torres,et al. Nomenclature for factors of the HLA system. , 2011, Bulletin of the World Health Organization.
[3] J. Neuberger,et al. A major histocompatibility complex class III allotype (C4B 2) associated with primary biliary cirrhosis (PBC). , 2008, Tissue antigens.
[4] R. Albertini,et al. HLA typing and autoantibodies in hepatitis B surface antigen-negative chronic active hepatitis. , 2008, Tissue antigens.
[5] A. Parés,et al. Primary biliary cirrhosis associated with HLA-DRw3. , 2008, Tissue antigens.
[6] P. Terasaki,et al. HLA determinants in chronic active liver disease: possible relation of HLA-Dw3 to prognosis. , 2008, Tissue antigens.
[7] G. Mieli-Vergani,et al. T-cell receptor constant beta germline gene polymorphisms and susceptibility to autoimmune hepatitis. , 1994, Gastroenterology.
[8] Roger Williams,et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis , 1994, Hepatology.
[9] G. Mieli-Vergani,et al. Human leukocyte antigen A1‐B8‐DR3‐DQ2‐DPB1*0401 extended haplotype in autoimmune hepatitis , 1993, Hepatology.
[10] P. Johnson,et al. Meeting report: International autoimmune hepatitis group , 1993, Hepatology.
[11] Broome. HLA class II antigens: Association with susceptibility and resistance to primary sclerosing cholangitis , 1993 .
[12] W. Mehal. COMPLEMENT C4B2 AND HLA DR8 GENOTYPING EXPLAINS THEIR KNOWN ASSOCIATIONS IN PBC , 1993 .
[13] N. Mizuki,et al. Association of primary biliary cirrhosis with human leukocyte antigen DPB1*0501 in Japanese patients , 1993, Hepatology.
[14] D. Wiley,et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.
[15] R. Chapman,et al. Primary biliary cirrhosis: contribution of HLA class II allele DR8. , 1993, The Quarterly journal of medicine.
[16] C. Toze,et al. Early-onset autoimmune hepatitis is associated with a C4A gene deletion. , 1993, Gastroenterology.
[17] D. Geraghty. Structure of the HLA class I region and expression of its resident genes. , 1993, Current opinion in immunology.
[18] C Anasetti,et al. Role of the mixed lymphocyte culture reaction in predicting acute graft-versus-host disease after marrow transplants from haploidentical and unrelated donors. , 1993, Transplantation proceedings.
[19] J. Neefjes,et al. Cell biology of antigen presentation. , 1993, Current opinion in immunology.
[20] H. Rammensee,et al. MHC molecules as peptide receptors. , 1993, Current opinion in immunology.
[21] J. Bodmer,et al. HLA-A locus alleles identified by sequence specific PCR , 1993, The Lancet.
[22] B. Portmann,et al. Susceptibility to primary biliary cirrhosis is associated with the HLA‐DR8‐DQB1*0402 haplotype , 1992, Hepatology.
[23] T. Starzl,et al. HLA antigens in primary sclerosing cholangitis. , 1992, Transplantation proceedings.
[24] J. Hansen,et al. SEROLOGICAL AND MOLECULAR ANALYSIS OF HLA IN ISRAELI PRIMARY SCLEROSING CHOLANGITIS PATIENTS , 1992, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[25] Charles A. Janeway,et al. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs , 1992, Nature.
[26] J. Bodmer,et al. Nomenclature for factors of the HLA system, 1991 , 1992, Human immunology.
[27] Dean R. Madden,et al. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC , 1992, Cell.
[28] J. Bodmer,et al. Nomenclature for Factors of the HLA System, 1991 , 1992, Immunobiology.
[29] H. Inoko,et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. , 1992, Gastroenterology.
[30] T. Saibara,et al. HLA DRw8 and primary biliary cirrhosis. , 1992, Gastroenterology.
[31] J. Sacchettini,et al. Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[32] William S. Lane,et al. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.
[33] E. Unanue,et al. Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[34] R. Vaughan,et al. Amino acid substitutions at position 38 of the DRβ polypeptide confer susceptibility to and protection from primary sclerosing cholangitis , 1992 .
[35] J. Villadangos,et al. Role of binding pockets for amino-terminal peptide residues in HLA-B27 allorecognition. , 1992, Journal of immunology.
[36] K. Einarsson,et al. HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis. , 1992, Gut.
[37] A Sette,et al. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.
[38] A. Goldberg,et al. Proteolysis, proteasomes and antigen presentation , 1992, Nature.
[39] O. Olerup,et al. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. , 1992, Tissue antigens.
[40] T Spies,et al. Allelic variants of the human putative peptide transporter involved in antigen processing. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[41] D. Finley,et al. A controlled breakdown: Antigen processing and the turnover of viral proteins , 1992, Cell.
[42] G. Nepom,et al. Differential expression of related HLA class II DQ beta genes caused by nucleotide variation in transcriptional regulatory elements. , 1992, Journal of immunology.
[43] M. Sheehy. HLA and Insulin-Dependent Diabetes. A protective perspective , 1992, Diabetes.
[44] J. Trowsdale,et al. COMPLEXITY IN THE MAJOR HISTOCOMPATIBILITY COMPLEX , 1992, European journal of immunogenetics.
[45] R. Wiesner,et al. Prognostic features and role of liver transplantation in severe corticosteroid‐treated autoimmune chronic active hepatitis , 1992, Hepatology.
[46] G. Bein,et al. Rapid HLA-DRB1 genotyping by nested PCR amplification. , 1992, Tissue antigens.
[47] R. Germain,et al. Presentation of antigen by mixed isotype class II molecules in normal H- 2d mice , 1992, The Journal of experimental medicine.
[48] R. Vries. 1991 MACK FORSTER AWARD LECTURE REVIEW , 1992 .
[49] J. Ragoussis,et al. Map of the human MHC. , 1991, Immunology today.
[50] O. Rötzschke,et al. Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway. , 1991, Immunology today.
[51] M. Manns,et al. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. , 1991, Gastroenterology.
[52] A. Rudensky,et al. Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.
[53] S. Beck,et al. Second proteasome-related gene in the human MHC class II region , 1991, Nature.
[54] D. R. Madden,et al. Identification of self peptides bound to purified HLA-B27 , 1991, Nature.
[55] H. Inoko,et al. HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. , 1991, Tissue antigens.
[56] H. Inoko,et al. Modified PCR-RFLP method for HLA-DPB1 and -DQA1 genotyping. , 1991, Tissue antigens.
[57] J. Chapman,et al. Survival of DNA HLA-DR typed and matched cadaver kidney transplants , 1991, The Lancet.
[58] Andrew J. McMichael,et al. Common West African HLA antigens are associated with protection from severe malaria , 1991, Nature.
[59] P. Parham,et al. HLA CLASS I NUCLEOTIDE SEQUENCES, 1991 , 1991, Immunobiology.
[60] E. Thorsby,et al. Particular HLA-DQ αβ Heterodimer Associated With IDDM Susceptibility in Both DR4-DQw4 Japanese and DR4-DQw8/DRw8-DQw4 Whites , 1991, Diabetes.
[61] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[62] D. Wiley,et al. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.
[63] Roger Williams,et al. Susceptibility to autoimmune chronic active hepatitis: Human leukocyte antigens DR4 and A1‐B8‐DR3 are independent risk factors , 1991, Hepatology.
[64] R. Vaughan. PCR‐SSO TYPING FOR HLA‐DRB ALLELES , 1991, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[65] P. Donaldson,et al. HLA‐DRB AND DQB TYPING BY A COMBINATION OF SEROLOGY, RESTRICTION FRAGMENT LENGTH POLYMORPHISM ANALYSIS AND OLIGONUCLEOTIDE PROBING , 1991, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[66] B. Portmann,et al. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis , 1991, Hepatology.
[67] G. Nepom,et al. Allelic polymorphism in transcriptional regulatory regions of HLA-DQB genes , 1991, The Journal of experimental medicine.
[68] S. Beck,et al. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters , 1990, Nature.
[69] R. Demars,et al. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway , 1990, Nature.
[70] H. Inoko,et al. Association of autoimmune hepatitis with HLA‐Bw54 and DR4 in Japanese patients , 1990, Hepatology.
[71] J. Bodmer,et al. The application of oligonucleotide probes to HLA class II typing of the DRB sub-region. , 1990, Tissue antigens.
[72] G. Nepom. A Unified Hypothesis for the Complex Genetics of HLA Associations With IDDM , 1990, Diabetes.
[73] P. Parham,et al. Apparent lack of MHC restriction in binding of class I HLA molecules to solid-phase peptides , 1990, The Journal of experimental medicine.
[74] R. Busuttil,et al. Association of primary sclerosing cholangitis with HLA-DRw52a. , 1990, The New England journal of medicine.
[75] R. Schwartz,et al. A cell culture model for T lymphocyte clonal anergy. , 1990, Science.
[76] J. Sprent,et al. T cell reactivity to MHC molecules: immunity versus tolerance. , 1990, Science.
[77] H. Mcdevitt,et al. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[78] D. Vergani,et al. Activation of the complement system in primary sclerosing cholangitis. , 1989, Gastroenterology.
[79] L. Fugger,et al. NcoI Restriction Fragment Length Polymorphism (RFLP) of the Tumour Necrosis Factor (TNFα) Region in Primary Biliary Cirrhosis and in Healthy Danes , 1989, Scandinavian journal of immunology.
[80] G. Morahan,et al. Tolerance of class I histocompatibility antigens expressed extrathymically , 1989, Nature.
[81] J. Levy,et al. Physical association between MHC class I molecules and immunogenic peptides , 1989, Nature.
[82] H. Chapel,et al. COMPLEMENT SYSTEM PROTEIN C4 AND SUSCEPTIBILITY TO HYDRALAZINE-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS , 1989, The Lancet.
[83] D. Longo,et al. Positive selection of CD4-CD8+ T cells in the thymus of normal mice , 1989, Nature.
[84] P. Parham,et al. Direct binding of influenza peptides to class I HLA molecules , 1989, Nature.
[85] A. McMichael,et al. Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[86] E. Appella,et al. Mechanisms influencing the immunodominance of T cell determinants , 1988, The Journal of experimental medicine.
[87] David M. Kranz,et al. Positive and negative selection of an antigen receptor on T cells in transgenic mice , 1988, Nature.
[88] P. Marrack,et al. The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens , 1988, Nature.
[89] R. Pemberton,et al. Competition between unrelated peptides recognized by H-2-Kd restricted T cells. , 1988, Journal of immunology.
[90] Y. Uematsu,et al. Thymic major histocompatibility complex antigens and the αβ T-cell receptor determine the CD4/CD8 phenotype of T cells , 1988, Nature.
[91] D. Wiley,et al. Evidence that multiple residues on both the α-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor , 1988, Cell.
[92] D. Wiley,et al. A hypothetical model of the foreign antigen binding site of Class II histocompatibility molecules , 1988, Nature.
[93] D. Middleton,et al. A DNA‐RFLP TYPING SYSTEM THAT POSITIVELY IDENTIFIES SEROLOGICALLY WELL‐DEFINED AND ILL‐DEFINED HLA‐DR AND DQ ALLELES, INCLUDING DRw10 , 1988, Transplantation.
[94] K. Mullis,et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.
[95] H. Orr,et al. Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[96] R. Albertini,et al. Immunogenetic studies of autoimmune chronic active hepatitis: HLA, immunoglobulin allotypes and autoantibodies , 1987, Hepatology.
[97] F. Alvarez,et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of “autoimmune” hepatitis , 1987, Hepatology.
[98] M. Kaplan,et al. Histocompatibility antigens in primary biliary cirrhosis. , 1987, The American journal of gastroenterology.
[99] J. Todd,et al. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus , 1987, Nature.
[100] M. A. Saper,et al. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens , 1987, Nature.
[101] M. A. Saper,et al. Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.
[102] I. Dunham,et al. Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[103] V. Lotteau,et al. A novel HLA class II molecule (DRα–sDQβ) created by mismatched isotype pairing , 1987, Nature.
[104] G. Gores,et al. Primary biliary cirrhosis: Associations with class II major histocompatibility complex antigens , 1987, Hepatology.
[105] 張超,et al. 受體(Receptor)醫學 , 1987 .
[106] R. Wright,et al. PERSISTENT MEASLES VIRUS GENOME IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS , 1987, The Lancet.
[107] Robert P. Erickson,et al. Natural history of the major histocompatibility complex , 1987 .
[108] A. McMichael,et al. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2 , 1987, Nature.
[109] P. Marrack,et al. T cell tolerance by clonal elimination in the thymus , 1987, Cell.
[110] K. Welsh. Natural History of the Major Histocompatibility Complex , 1987 .
[111] Henry A. Erlich,et al. Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes , 1986, Nature.
[112] W. Mcdonald,et al. VIRAL INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS AND HLA-DR MATCHED CONTROLS , 1986, Brain : a journal of neurology.
[113] A. McMichael,et al. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides , 1986, Cell.
[114] J. McCubrey,et al. Transfer of specificity by murine α and β T-cell receptor genes , 1986, Nature.
[115] J. Sprent,et al. Identity of cells that imprint H–2-restricted T-cell specificity in the thymus , 1986, Nature.
[116] D. Vergani,et al. GENETICALLY DETERMINED LOW C4: A PREDISPOSING FACTOR TO AUTOIMMUNE CHRONIC ACTIVE HEPATITIS , 1985, The Lancet.
[117] M. Bassendine,et al. HLA-DR antigens in primary biliary cirrhosis: lack of association. , 1985, Gut.
[118] M. Oldstone,et al. Virus persists in beta cells of islets of Langerhans and is associated with chemical manifestations of diabetes. , 1984, Science.
[119] D. Bentley,et al. A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B , 1984, Nature.
[120] D. Jewell,et al. Ulcerative colitis and persistent liver dysfunction. , 1983, The Quarterly journal of medicine.
[121] R. Chapman,et al. Association of primary sclerosing cholangitis with HLA-B8. , 1983, Gut.
[122] E. Schrumpf,et al. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. , 1982, Scandinavian journal of gastroenterology.
[123] J. Schifferli,et al. Inhibition of immune precipitation by complement. , 1980, Clinical and experimental immunology.
[124] S. Sherlock,et al. Primary or secondary sicca complex? Investigation in primary biliary cirrhosis by histocompatibility testing. , 1980, British medical journal.
[125] B. Dupont,et al. Increased Frequency of HLA‐DRW4 in Chronic Active Hepatitis 1 , 1978, Vox sanguinis.
[126] K. Isselbacher,et al. Circulating immune complexes and complement activation in primary biliary cirrhosis. , 1978, The New England journal of medicine.
[127] A. Eddleston,et al. Histocompatibility Antigens in Active Chronic Hepatitis and Primary Biliary Cirrhosis , 1974, British medical journal.
[128] V. Schuermans,et al. IMPAIRED NEUTROPHIL PHAGOCYTOSIS , 1974 .
[129] J. Bach,et al. SELF AND NOT-SELF , 1974 .
[130] R. Zinkernagel,et al. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system , 1974, Nature.
[131] A. Hagemeijer,et al. Human antigen and enzyme markers in man-Chinese hamster somatic cell hybrids: evidence for synteny between the HL-A, PGM3, ME1, and IPO-B loci. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[132] I. Mackay,et al. Association of autoimmune active chronic hepatitis with HL-A1,8. , 1972, Lancet.
[133] R. Snyderman,et al. Neutralization of Sensitized Virus by the Fourth Component of Complement , 1969, Science.
[134] J. Sebus,et al. COAGULATION CHANGES AFTER INJURY. , 1964, Lancet.
[135] J. Idle,et al. Analysis of H LA-class-li-encoded antigen-processing genes TAP1 and TAP2 in primary biliary cirrhosis , 1994 .
[136] R. Chapman,et al. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. , 1994, Gastroenterology.
[137] M. Bunce,et al. Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP): identification of serological and non-serologically defined HLA-C alleles including several new alleles. , 1994, Tissue antigens.
[138] J. Monaco,et al. A molecular model of MHC class-I-restricted antigen processing. , 1992, Immunology today.
[139] R. de Vries. 1991 Mack Forster Award Lecture. HLA and disease: from epidemiology to immunotherapy. , 1992, European journal of clinical investigation.
[140] P Parham,et al. HLA class I nucleotide sequences, 1991. , 1991, Human immunology.
[141] J. Ragoussis,et al. Map of the human MHC. , 1991, Immunology today.
[142] Å. Lernmark,et al. HLA DR gene polymorphism in primary biliary cirrhosis , 1991 .
[143] H. Inoko,et al. HLA-DQB1 genotyping by a modified PCR-RFLP method combined with group-specific primers. , 1991, Tissue antigens.
[144] S. Kaufmann,et al. Heat shock proteins and the immune response. , 1990, Immunology today.
[145] O. James,et al. Epidemiology and genetics of primary biliary cirrhosis. , 1990, Progress in liver diseases.
[146] S. Lazàry,et al. Ela Disease Associations , 1989 .
[147] G. Ferrara,et al. HLA-DP typing by DNA amplification and hybridization with specific oligonucleotides. , 1989, Human immunology.
[148] J. Lalouel,et al. Restriction Fragment Length Polymorphism of HLA Genes: Summary of the Tenth International Workshop Southern Blot Analysis , 1989 .
[149] R. Wiesner,et al. The first 100 liver transplantations at the Mayo Clinic. , 1989, Mayo Clinic proceedings.
[150] J. H. Brown. A hypothetical model of the foreign antigen binding site of Class II histocompatibility molecules , 1988, Nature.
[151] J. Bidwell. DNA-RFLP analysis and genotyping of HLA-DR and DQ antigens. , 1988, Immunology today.
[152] K. Mullis,et al. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. , 1987, Methods in enzymology.
[153] L. Hood,et al. The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition. , 1986, Annual review of immunology.
[154] M. Baur,et al. Reference Tables of Two-Locus Haplotype Frequencies for All MHC Marker Loci , 1984 .
[155] A. Fingerhut,et al. Nontraumatic Intramural Hematoma of the Duodenum , 1983 .
[156] K. Kobayashi,et al. HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis. , 1983, Digestion.
[157] I. Mackay,et al. Interaction of HLA and Gm in autoimmune chronic active hepatitis. , 1981, Clinical and experimental immunology.
[158] I. Mackay,et al. HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies. , 1980, Gastroenterology.
[159] N. Morling,et al. HLA and disease , 1980 .
[160] C. Fathman. HLA and disease associations. , 1978, Mayo Clinic proceedings.